Literature DB >> 18056231

The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses.

Andrew C Leon1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18056231     DOI： 10.1176/appi.ajp.2007.07050775

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  10 in total

Review 1.  Do antidepressants really work? A clinicians' guide to evaluating the evidence.

Authors:  Michael E Thase
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

2.  Genome-wide association study of antidepressant treatment-emergent suicidal ideation.

Authors:  Andreas Menke; Katharina Domschke; Darina Czamara; Torsten Klengel; Johannes Hennings; Susanne Lucae; Bernhard T Baune; Volker Arolt; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

3.  Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review.

Authors:  Elena Dragioti; Marco Solmi; Angela Favaro; Paolo Fusar-Poli; Paola Dazzan; Trevor Thompson; Brendon Stubbs; Joseph Firth; Michele Fornaro; Dimitrios Tsartsalis; Andre F Carvalho; Eduard Vieta; Philip McGuire; Allan H Young; Jae Il Shin; Christoph U Correll; Evangelos Evangelou
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

4.  Fluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior.

Authors:  Stal Saurav Shrestha; Eric E Nelson; Jeih-San Liow; Robert Gladding; Chul Hyoung Lyoo; Pam L Noble; Cheryl Morse; Ioline D Henter; Jeremy Kruger; Bo Zhang; Stephen J Suomi; Per Svenningsson; Victor W Pike; James T Winslow; Ellen Leibenluft; Daniel S Pine; Robert B Innis
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

Review 5.  Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.

Authors:  Corrado Barbui; Eleonora Esposito; Andrea Cipriani
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

6.  Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Authors:  Laurence Y Katz; Anita L Kozyrskyj; Heather J Prior; Murray W Enns; Brian J Cox; Jitender Sareen
Journal:  CMAJ       Date:  2008-04-08       Impact factor: 8.262

7.  Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

Authors:  A A Nierenberg; M M Husain; M H Trivedi; M Fava; D Warden; S R Wisniewski; S Miyahara; A J Rush
Journal:  Psychol Med       Date:  2009-05-22       Impact factor: 7.723

Review 8.  A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Authors:  Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2011-09       Impact factor: 5.744

Review 9.  Antidepressants and Suicide Risk: A Comprehensive Overview.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Elisa Ambrosi; Gloria Giordano; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-30

10.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.